National Immunisation Program Schedule 1 July 2020 
Childhood vaccination 
(also see influenza vaccine and additional vaccination for people with medical risk conditions)
Age
Disease
Vaccine Brand
Notes
Birth
H-B-Vax® II Paediatric or 
Hepatitis B vaccine: Should be given to all infants as soon as practicable after birth.  
• Hepatitis B (usually offered in hospital)
Engerix B® Paediatric
The greatest benefit is if given within 24 hours, and must be given within 7 days.
2 months
• Diphtheria, tetanus, pertussis (whooping cough), hepatitis B,
Infanrix® hexa
Rotavirus vaccine: First dose must be given by 14 weeks of age.
Can be given from  
polio, Haemophilus influenzae type b (Hib)
6 weeks of age
• Rotavirus
Rotarix®
Meningococcal B vaccine: All Aboriginal and Torres Strait Islander children from 6 weeks of age, 
with a three year catch-up program for Aboriginal and Torres Strait Islander children aged 
• Pneumococcal
Prevenar 13®
less than 2 years old until 30 June 2023. Refer to the Australian Immunisation Handbook (the 
• Meningococcal B (Indigenous children)
Bexsero®
Handbook) for dose intervals. 
4 months
• Diphtheria, tetanus, pertussis (whooping cough), hepatitis B,
Infanrix® hexa
Rotavirus vaccine: The second dose must be given by 24 weeks of age.
polio, Haemophilus influenzae type b (Hib)
• Rotavirus
Rotarix®
ACT 1982 (CTH) 
• Pneumococcal
Prevenar 13®
HEALTH
• Meningococcal B (Indigenous children)
Bexsero®
6 months
• Diphtheria, tetanus, pertussis (whooping cough), hepatitis B,
Infanrix® hexa       
Pneumococcal vaccine: An additional (3rd) dose of 13vPCV is required for Indigenous children 
polio, Haemophilus influenzae type b (Hib)
living in WA, NT, SA, Qld, and all children with specified medical risk conditions for pneumococcal 
• Pneumococcal  (All children with specified medical risk
disease. Refer to the Handbook.
Prevenar 13®
conditions)
Meningococcal B vaccine: An additional (3rd) dose of Bexsero® is required for Indigenous children 
• Pneumococcal (Indigenous children living in WA, NT,
INFORMATION 
Prevenar 13®
with specified medical risk conditions for meningococcal disease. Refer to the Handbook.  
SA, Qld)
• Meningococcal B (Indigenous children with specified
Bexsero®
medical risk conditions)
12 months
• Meningococcal ACWY
Nimenrix®
M-M-R® II or 
• Measles, mumps, rubella
Priorix®
BY THE DEPARTMENT OF 
• Pneumococcal
Prevenar 13®
THIS DOCUMENT HAS BEEN RELEASED UNDER 
• Meningococcal B (Indigenous children)
Bexsero®
THE FREEDOM OF 
• Haemophilus influenzae type b (Hib)
ActHIB®
Hepatitis A vaccine: First dose of the 2-dose hepatitis A vaccination schedule if not previously 
18 months
• Measles, mumps, rubella, varicella (chickenpox)
Priorix-Tetra® or ProQuad® 
received a dose. The second dose is now scheduled at 4 years.
• Diphtheria, tetanus, pertussis (whooping cough)
Infanrix® or Tripacel®
• Hepatitis A (Indigenous children in WA, NT, SA, Qld)
Vaqta® Paediatric
4 years
• Diphtheria, tetanus, pertussis (whooping cough), polio
Infanrix® IPV or Quadracel®
Pneumococcal vaccine: Administer first dose of 23vPPV at age 4 years, followed by second  
• Pneumococcal (All children with specified medical risk
dose of 23vPPV at least 5 years later. Refer to the Handbook for risk conditions. 
Pneumovax 23®   
conditions)
Hepatitis A vaccine: Not required if previously received 2 doses (first dose at age ≥12 months)  
• Pneumococcal (Indigenous children living in WA, NT,
Pneumovax 23®   
at least 6 months apart.
SA, Qld)
• Hepatitis A (Indigenous children in WA, NT, SA, Qld)
Vaqta® Paediatric
FOI 3079
1 of 2
DOCUMENT 13

---

 Adolescent vaccination 
(also see influenza vaccine and additional vaccination for people with medical risk conditions)
Age
Disease
Vaccine Brand
Notes
HPV vaccine: Observe Gardasil®9 dosing schedules by age and at-risk conditions. 
12–13 years 
• Diphtheria, tetanus, pertussis (whooping cough)
Boostrix®
9 to <15 years: 2 doses, 6 months minimum interval.  ≥15 years and/or have certain 
(School program)
• Human papillomavirus (HPV)
Gardasil®9 
medical conditions: 3 doses, 0, 2 and 6 month schedule.  Only 2 doses funded on the NIP 
unless a 12–<15 year old has certain medical risk factors. 
14–16 years 
• Meningococcal ACWY
Nimenrix®
(School program)
Adult vaccination 
 (also see influenza vaccine  and additional vaccination for people with medical risk conditions)
Age
Disease
Vaccine Brand
Notes
50 years and over
Pneumococcal vaccine: Administer a dose of 13vPCV, followed by first dose of 23vPPV 12 months 
 
• Pneumococcal  (Indigenous adults)
Prevenar 13® and Pneumovax 23®
later (2–12 months acceptable), then second dose of 23vPPV at least 5 years later. 
70 years and over 
• Pneumococcal (non-Indigenous adults)
Prevenar 13®
70–79 years
Shingles vaccine: All people aged 70 years old with a five year catch-up program for people aged 
• Shingles (herpes zoster)
Zostavax®
71–79 years old until 31 October 2021. 
Pregnant women
Pertussis vaccine: Single dose recommended each pregnancy, ideally between 20–32 weeks,  
•
ACT 1982 (CTH) 
Pertussis (whooping cough)
Boostrix® or Adacel®
but may be given up until delivery.
HEALTH
Additional vaccination for people with medical risk conditions
Age/risk condition
Disease
Vaccine Brand
Notes
All people with asplenia, 
hyposplenia, complement 
• Meningococcal ACWY
Nimenrix®
Meningococcal vaccines: Refer to the Handbook for dosing schedule. The number of doses 
deficiency and those undergoing 
•
INFORMATION 
Meningococcal B
Bexsero®
required vary with age.
treatment with eculizumab
People ≥5 years with asplenia 
Hib vaccine: A single dose is required if the person was not vaccinated in infancy or incompletely 
• Haemophilus influenzae type b (Hib)
Act-Hib®
vaccinated. (Note that all children aged <5 years are recommended to complete Hib vaccination 
or hyposplenia
regardless of asplenia or hyposplenia)
People <12 months of age with 
Pneumococcal vaccine: An additional (3rd) dose of 13vPCV is required at 6 months of age, 
Prevenar 13® and 
followed by a routine booster at 12 months (all children), then a first dose of 23vPPV at age  
conditions that increase their risk 
• Pneumococcal
Pneumovax 23®
4 years, followed by second dose of 23vPPV at least 5 years later. Refer to the Handbook for  
BY THE DEPARTMENT OF 
of pneumococcal disease
risk conditions.  
THIS DOCUMENT HAS BEEN RELEASED UNDER 
People ≥12 months of age with 
Prevenar 13® and 
THE FREEDOM OF 
Pneumococcal vaccine: Administer a dose of 13vPCV at diagnosis followed by 2 doses of 23vPPV.  
conditions that increase their risk 
• Pneumococcal
Pneumovax 23®
Refer to the Handbook for dose intervals and risk conditions. 
of pneumococcal disease
Funded annual influenza vaccination 
All people aged less than 20 years are eligible for free 
State/Territory  
Contact Number
(Refer to annual ATAGI advice on seasonal influenza vaccines)
catch-up vaccines. The number and range of vaccines 
Australian Capital Territory   
(02) 5124 9800 
and doses that are eligible for NIP funded catch-up is 
New South Wales
1300 066 055 
different for people aged less than 10 years and those 
Children 6 months to less than 5 years of age
Northern Territory
(08) 8922 8044 
aged 10–19 years. 
Queensland 
HEALTH  (13  4325  84)
People 6 months and over with specified medical risk conditions
Adult refugees and humanitarian entrants are eligible 
South Australia   
1300 232 272 
People 65 years and over
for free catch-up vaccines. Refer to NIP catch-up fact 
Tasmania   
1800 671 738
Pregnant women
sheets.
Victoria   
1300 882 008
Western Australia        
(08) 9321 1312 
All Aboriginal and Torres Strait Islander people 6 months and over
T000869
FOI 3079
2 of 2
DOCUMENT 13
D
Last updated September 2020

---